DPP4 inhibitors have also been evaluated for their role in inflammation associated with DN, and it has been reported that they can attenuate the inflammasome activation and the progression of DN in T2DM mice [36]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.